ImpediMed Limited

Symbol: IPDQF

PNK

0.092

USD

Market price today

  • -11.8113

    P/E Ratio

  • 0.5052

    PEG Ratio

  • 186.14M

    MRK Cap

  • 0.00%

    DIV Yield

ImpediMed Limited (IPDQF) Stock Price & Analysis

Shares Outstanding

2023.25M

Gross Profit Margin

0.84%

Operating Profit Margin

-2.05%

Net Profit Margin

-1.89%

Return on Assets

-0.34%

Return on Equity

-0.52%

Return on Capital Employed

-0.42%

Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Mr. Shashi Tripathi
Full-time employees:76
City:Pinkenba
Address:50 Parker Court
IPO:2012-09-25
CIK:

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

General Outlook

In simple terms, ImpediMed Limited has 2023.25 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.837% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.052%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -1.894%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.339% return, is a testament to ImpediMed Limited's adeptness in optimizing resource deployment. ImpediMed Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.519%. Furthermore, the proficiency of ImpediMed Limited in capital utilization is underscored by a remarkable -0.419% return on capital employed.

Stock Prices

ImpediMed Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.08, while its low point bottomed out at $0.08. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ImpediMed Limited's stock market.
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2023?

There are stock number shares outstanding of ImpediMed Limited (IPDQF) on the PNK in 2023.

What is P/E ratio of enterprise in 2023?

The current P/E ratio of enterprise is -11.811 in 2023.

What is the ticker symbol of ImpediMed Limited stock?

The ticker symbol of ImpediMed Limited stock is IPDQF.

What is company IPO date?

IPO date of ImpediMed Limited is 2012-09-25.

What is company current share price?

Current share price is 0.092 USD.

What is stock market cap today?

The market cap of stock today is 186139000.000.

What is PEG ratio in 2023?

The current 0.505 is 0.505 in 2023.

What is the number of employees in 2023?

In 2023 the company has 76.